Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European journal of drug metabolism and pharmacokinetics

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03190023PMID 10716059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Pharmacokinetics and Bioavailability of Dihydroartemisinin, Arteether, Artemether, Artesunic Acid and Artelinic Acid in Rats

  1998cited by this paper
• Anorectic Toxicity of Dih Ydroartemisinin, Artemether, and Arteether in Rats Following Multiple Intramuscular Doses

  1998cited by this paper
• Dose-dependent brainstem neuropathology following repeated arteether administration in rats.

  1998cited by this paper
• Exposure and Risk Assessment with Respect to Contaminated Soil: Significance of Biomarkers and Bioavailability

  1997cited by this paper
• Arteether: risks of two-week administration in Macaca mulatta.

  1997influential reference
• Efficacy of alpha,beta-arteether in acute uncomplicated P. falciparum malaria.

  1997cited by this paper
• Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro.

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Arteether administration in humans: preliminary studies of pharmacokinetics, safety and tolerance.

  1994cited by this paper
• Artemisinin: current status.

  1994cited by this paper
• Fatal neurotoxicity of arteether and artemether.

  1994cited by this paper
• Clinical trials of artemisinin and its derivatives in the treatment of malaria in China.

  1994cited by this paper
• Pharmacology of alpha/beta arteether--a potential antimalarial drug.

  1989cited by this paper
• Amphetamine enantiomers and rat consummatory behavior: a new perspective.

  1989cited by this paper
• Follow-up observation on the therapeutic effects and remote reactions of artemisinin (Qinghaosu) and artemether in treating malaria in pregnant woman.

  1989cited by this paper
• Follow-up observation on the therapeutic effects and remote reactions of artemisinin (Qinghaosu) and artemether in treating malaria in pregnant woman.

  1989cited by this paper
• Arteether, a new antimalarial drug: synthesis and antimalarial properties.

  1988cited by this paper
• Artemisinin, a potent antimalarial agent: general pharmacological properties

  1988cited by this paper
• A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria

  1987cited by this paper
• A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria.

  1987cited by this paper
• The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.

  1986cited by this paper
• Qinghaosu (artemisinin): an antimalarial drug from China

  1985cited by this paper
• Qinghaosu (artemisinin): an antimalarial drug from China.

  1985cited by this paper
• [Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits].

  1984cited by this paper
• [Effects of Qinghaosu (artemisinine) in oil on ultrastructure of the myocardium in rhesus monkeys].

  1983cited by this paper
• Local muscle damage and oily vehicles: a study on local reactions in rabbits after intramuscular injection of neuroleptic drugs in aqueous or oily vehicles.

  1983cited by this paper
• Clinical Pharmacokinetics: Concepts and applications.

  1983cited by this paper
• The antimalarial and toxic effect of artesunate on animal models.

  1982cited by this paper
• Theophylline disrupts diurnal rhythms of humoral factors with loss of meal cyclicity.

  1982cited by this paper
• Studies on the toxicity of qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.

  1982cited by this paper
• Clinical studies on the treatment of malaria with qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.

  1982cited by this paper
• Applied biopharmaceutics and pharmacokinetics

  1980cited by this paper
• Local toxic effects of broad-spectrum antibiotics following injection.

  1961cited by this paper
• Local toxic effects of broad-spectrum antibiotics following injection.

  1961cited by this paper

• The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus

  2020cites this paper
• Pharmacokinetic and Pharmacodynamic Profiles of Rapid- and Slow-Acting Antimalarial Drugs

  2019cites this paper
• Synthesis, cytotoxicity and antiplasmodial activity of novel ferrocenyl-artemisinin hybrids

  2019cites this paper
• Synthesis and biological evaluation of novel 11-azaartemisinin derivatives

  2017cites this paper
• Novel anti-malarial combinations and their toxicity

  2014cites this paper
• Malaria and artemisinin derivatives: an updated review.

  2013cites this paper
• Pharmacokinetic (PK) and Pharmacodynamic Profiles of Artemisinin Derivatives Influence Drug Neurotoxicity in Animals

  2012influential citation
• Toxicokinetic and toxicodynamic (TK/TD) evaluation to determine and predict the neurotoxicity of artemisinins.

  2011cites this paper
• Artesunate and artelinic acid: association of embryotoxicity, reticulocytopenia, and delayed stimulation of hematopoiesis in pregnant rats.

  2011cites this paper
• Neurological assessments after treatment with the antimalarial β-arteether in neonatal and adult rats.

  2011cites this paper
• WITHDRAWN. Neurological assessments after treatment with the antimalarial β-arteether in neonatal and adult rats.

  2011cites this paper
• Supporting capacity for research on malaria in Africa

  2010cites this paper
• Toxicity of the antimalarial artemisinin and its dervatives

  2010cites this paper
• Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials.

  2009cites this paper
• Pharmacokinetic and Toxicological Profile of Artemisinin Compounds: An Update

  2009cites this paper
• Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester.

  2009cites this paper
• Comparison of HPLC with electrochemical detection and LC-MS/MS for the separation and validation of artesunate and dihydroartemisinin in animal and human plasma.

  2008cites this paper
• Artemisinins

  2005cites this paper
• Artemisinin derivatives: toxic for laboratory animals, safe for humans?

  2004cites this paper
• In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.

  2003cites this paper
• A short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic beta-sulfonyl-endoperoxides.

  2003cites this paper
• A sensitive and selective liquid chromatographic/electrospray ionization tandem mass spectrometric assay for the simultaneous quantification of alpha-,beta-arteether and its metabolite dihydroartemisinin in plasma, useful for pharmacokinetic studies.

  2003cites this paper
• Potential long-term toxicity of repeated orally administered doses of artemether in rats.

  2002cites this paper
• Pharmacokinetics of Artemisinin-Type Compounds

  2000cites this paper